Trailing-twelve-month (TTM) revenue is $14.52 Million with a year-over-year growth of +48.27%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $2,172,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-09-30 |
| Q4 FY2025Period ended 2025-12-31 | $8,978,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-24 |
| Q1 FY2026Period ended 2026-03-31 | $1,685,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-31 |
| Q2 FY2026Period ended 2026-06-30 | $1,685,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-14 |
| TTM revenue | $14,520,000 |
Current P/S: $21,646,571 market capitalization ÷ $14,520,000 TTM revenue = 1.49x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T20:00:00.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $1.69M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T21:08:43.464Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20192019-12-31 · USD | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Product | $44M | $12M | $2M | $2M | $1M | $751,000 |
| Service | $22M | $12M | $14M | $12M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20192019-12-31 · USD | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| CHINA | $2M | $2M | $2M | $2M | $2M | $2M |
| INDIA | $37M | $10M | $8M | $7M |
$14.52M
$14.52 Million
+48.27%
vs. $9.79M a year ago (TTM)
(12.89%)
5 Year compound annual growth rate
1 Year
+48.27%
3 Year
+3.56%
5 Year
(12.89%)
10 Year
(17.21%)
15 Year
(18.12%)
20 Year
(22.62%)
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $8.98M | ($1.90M) | (17.47%) |
| 2024 | $10.88M | ($4.88M) | (30.95%) |
| 2023 | $15.75M | +$1.73M | +12.32% |
| 2022 | $14.03M | ($1.90M) | (11.91%) |
| 2021 | $15.92M | ($8.39M) | (34.51%) |
| 2020 |
TTM Growth
+48.27%
3-Year CAGR
+3.56%
5-Year CAGR
(12.89%)
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T21:08:43.464Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-06-17.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $8M |
| $3M |
| JAPAN | $22M | $12M | $6M | $5M | $4M | $4M |
|---|
| Other Countries | $702,000 | $9,000 | N/A | N/A | N/A | N/A |
|---|
| TAIWAN, PROVINCE OF CHINA | $4M | N/A | N/A | N/A | N/A | N/A |
|---|
| $24.31M |
| ($41.51M) |
| (63.07%) |
| 2019 | $65.82M | ($50.12M) | (43.23%) |
| 2018 | $115.94M | +$17.65M | +17.96% |
| 2017 | $98.29M | +$18.11M | +22.58% |
| 2016 | $80.18M | ($36.92M) | (31.53%) |
